Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial - Wikidata - thesis-toulmin - TriplyDB

Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial

Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial

http://www.wikidata.org/entity/Q35160234

about

Pharmacotherapies for cannabis dependence State of the art treatments for cannabis dependence Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review Cannabinoid abuse and addiction: Clinical and preclinical findings The cannabis withdrawal syndrome: current insights Risks associated with the non-medicinal use of cannabis Time-course of the DSM-5 cannabis withdrawal symptoms in poly-substance abusers Individual mindfulness-based psychotherapy for cannabis or cocaine dependence: a pilot feasibility trial Oral fluid cannabinoids in chronic cannabis smokers during oral δ9-tetrahydrocannabinol therapy and smoked cannabis challenge Youth marijuana use: state of the science for the practicing clinician.Verbal learning in marijuana users seeking treatment: a comparison between depressed and non-depressed samples Nabilone therapy for cannabis withdrawal presenting as protracted nausea and vomiting BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.New Developments in Understanding and Treating Adolescent Marijuana Dependence Open-label pilot study of quetiapine treatment for cannabis dependence.Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network.Do withdrawal-like symptoms mediate increased marijuana smoking in individuals treated with venlafaxine-XR?Primary outcomes in two randomized controlled trials of treatments for cannabis use disorders.Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers.The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone.A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults.Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers.A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents.Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial.A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers Combining cognitive behavioral therapy and contingency management to enhance their effects in treating cannabis dependence: less can be more, more or less.Predictors of marijuana relapse in the human laboratory: robust impact of tobacco cigarette smoking status Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial.The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users Reward-related brain response and craving correlates of marijuana cue exposure: a preliminary study in treatment-seeking marijuana-dependent subjects Marijuana dependence: not just smoke and mirrors.Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders Cognitive behavioral therapy and the nicotine transdermal patch for dual nicotine and cannabis dependence: a pilot study Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings.Treatment of Cannabis Use Disorder: Current Science and Future Outlook.Pharmacokinetic and pharmacodynamic profile of supratherapeutic oral doses of Δ(9) -THC in cannabis users.Screening Medications for the Treatment of Cannabis Use Disorder.Evidence-based Treatment Options in Cannabis Dependency.

P2860

Q24187250-BB792073-5EB4-4206-B1B6-910AE8AFD67E Q24607810-EABCF09A-E2ED-4D8D-91AC-DCCEBED17B28 Q26746192-84D9D4D9-1B4C-43D1-91D0-C49486545BE8 Q26851944-C68FE974-53EC-47B0-A14F-5AF631985DB0 Q30313180-AA63763D-B966-46FA-AEA7-74FFCE93C656 Q30316580-5F2ACA3D-4BAD-43C0-92DE-A237C2E609B6 Q33587307-79C56473-97C2-4ACA-9BC6-55C3679B6C7A Q33824942-EEB95A76-2F82-4B5A-97C1-76490EC92C33 Q33915426-413006AC-0567-4A24-A439-C82418DAB85A Q34069074-CC78C885-7139-41B0-9900-039B6C7FEE58 Q34081518-32EF73E1-DDFF-45A7-B51D-484336243926 Q34235592-6A9FB1DD-AE5F-43A9-8965-0D91890599FD Q34277168-33CC4A0F-B5AD-4212-8FBB-874C79A882C7 Q34288989-1B16D5B6-8414-4141-BE34-97E792E52CC4 Q34512547-650CB6AB-62B8-4A15-9F6C-9A6997C5D349 Q34613783-EB93824D-C214-4C26-8BFC-1B236A701E77 Q34615910-63708332-31AD-4B9D-ADEE-5155E310644E Q35291735-DD25B7C6-D020-46B8-B950-B5F13DCB843E Q35685121-0CA9CFD8-802D-4B3E-AE1F-B42F8907A79F Q35911283-B4276952-4B80-4442-9EBE-5F1A94F79B38 Q35952033-52D8F7B0-42F6-4FD0-926C-1370D094EAE9 Q35982249-10FC70DD-2B02-4F1E-BBC3-BAEA72ACD1E5 Q36059911-F14C765D-C39A-4884-ACE6-2129CC335A34 Q36137192-3E24CB11-3DCD-4D76-966A-1DB167F1E7D7 Q36249079-856461D8-19E6-4C20-B0B8-05C0750D30FA Q36301495-C46581EC-4D53-4393-B1E3-A9FAB8743E9E Q36431952-17CA87DC-B286-4D75-A695-D5F022889086 Q36468008-C144104E-B21C-4D4B-92CB-E3D6C5F6DF14 Q36509285-71B111E1-F9F8-4D80-B6BF-F9F5A3E8D99E Q36536527-06D42A70-910C-49AB-B922-465F1732A7CA Q36595006-614F4057-893C-4E92-AA38-0623CC123486 Q36712200-6312839E-2E91-40DE-A29D-9F038119A916 Q36729404-1450A198-101D-43E1-9255-918914D0C8DD Q36794579-422E775F-9598-4283-B8FF-FE841090112B Q36810688-2A310E3E-EBCB-4F6B-8E65-2C7D35968D22 Q36932158-34DC3FD9-C940-498D-8EBC-1A1D222F14AC Q36936298-06F981A8-B59A-4A61-B02F-48FF710DF4FB Q36951509-BEE12968-D7A3-4A5D-A458-3BE1CD40DE36 Q37187618-10FEEA48-A1F6-4E10-BF49-997C65A3C94E Q37396986-9128757D-CF86-4309-BA04-0DDB7B9715B3

P2860

Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial

http://www.wikidata.org/entity/Q35160234

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Dronabinol for the treatment o ...... lind, placebo-controlled trial

@ast

Dronabinol for the treatment o ...... lind, placebo-controlled trial

@en

type

label

Dronabinol for the treatment o ...... lind, placebo-controlled trial

@ast

Dronabinol for the treatment o ...... lind, placebo-controlled trial

@en

prefLabel

Dronabinol for the treatment o ...... lind, placebo-controlled trial

@ast

Dronabinol for the treatment o ...... lind, placebo-controlled trial

@en

P1433

Q35160234-FB6C6B53-E616-4899-ADBC-87F81691EE9C

P1476

Q35160234-9E0BB668-AF44-4CD9-8FE6-CFC252FFF579

P2093

Q35160234-496FA6CE-CED7-49D3-8266-E48A84A77A1B

Q35160234-967DFD31-4AA9-4673-941A-483B7EC0949F

Q35160234-B5FDEF0B-B063-4CCD-B6AB-A4DEA1AD9D6A

Q35160234-CA3656F6-A9E2-4E5B-966A-6C8D570B6D53

Q35160234-CD1B40B8-6B9F-4620-9202-DB4902A0CAC1

Q35160234-D69EECCD-3DD3-4D2B-914B-B24AE24895B8

P2860

Q35160234-05AF94D1-F67E-4E6F-B6D6-BEC5AD67BED3

Q35160234-0D3F160D-FA30-4059-8046-929A58D2B9E2

Q35160234-0DFF1080-1A20-4570-8428-AA688FA8AB16

Q35160234-149B1609-373B-4AC3-BE4E-7B7402D57907

Q35160234-154F27FA-7FEC-4038-A811-31605616AA50

Q35160234-19B49230-32E9-4B7E-AC15-074E38F56C49

Q35160234-1A584149-9789-40D4-BFBC-9D4C8FAE66D8

Q35160234-22CE0547-F6BB-4FB2-ACBD-CAAB4C9C4EF2

Q35160234-234E72EC-5DC6-4579-8D19-6A876163C811

Q35160234-26B96B86-0822-44F9-A523-E2DD25D3FD59

P304

Q35160234-0C85FA78-6C04-4831-89C7-0FBE7BA4ADF0

P31

Q35160234-A19B846F-BDDF-4881-AB1E-D01E0CD08AE3

P356

Q35160234-97A07804-CA02-4333-A9E1-248363D80744

P433

Q35160234-61ED914E-B71A-44FC-876A-157FB135FD57

P478

Q35160234-F5B2C305-60E5-481D-9697-6670C9B08CE1

P577

Q35160234-27BCD4AF-FC34-491E-B9AC-02D05F883EB5

P5875

Q35160234-2118A9C6-8121-472E-A55A-8212FE30DF36

P698

Q35160234-27973AEF-527A-4D65-A21E-92F37D64E9F9

P921

Q35160234-2083D1A3-2C41-4B58-AA59-DC7DA2D9736E

Q35160234-379BB99B-43B2-4593-9017-3EA5AE0A6045

P932

Q35160234-CEBFBB55-A1AE-471E-9B1C-C448D55A04EE

P356

J.DRUGALCDEP.2010.12.010

P1433

Drug and Alcohol Dependence

P1476

Dronabinol for the treatment o ...... lind, placebo-controlled trial

@en

P2093

Daniel J Brooks

http://www.w3.org/2001/XMLSchema#string

Edward V Nunes

http://www.w3.org/2001/XMLSchema#string

Frances R Levin

http://www.w3.org/2001/XMLSchema#string

John J Mariani

http://www.w3.org/2001/XMLSchema#string

Martina Pavlicova

http://www.w3.org/2001/XMLSchema#string

Wendy Cheng

http://www.w3.org/2001/XMLSchema#string

P2860

Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence

Nicotine replacement therapy for smoking cessation

Buprenorphine: a unique drug with complex pharmacology

Pharmacotherapy for cannabis dependence: how close are we?

Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers: a randomized controlled trial.

The COMBINE SAFTEE: a structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field.

Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol.

Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial

Opioid antagonism enhances marijuana's effects in heavy marijuana smokers

P304

142-150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DRUGALCDEP.2010.12.010

http://www.w3.org/2001/XMLSchema#string

P433

1-3

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49826111

http://www.w3.org/2001/XMLSchema#string

P698

21310551

http://www.w3.org/2001/XMLSchema#string

P921

tetrahydrocannabinol

P932

3154755

http://www.w3.org/2001/XMLSchema#string